| 0 (0%) | 12-26 20:14 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 213.21  |
1-year : | 224.8 |
| Resists | First : | 182.54 |
Second : | 192.47 |
| Pivot price | 172.86  |
|||
| Supports | First : | 166.49 |
Second : | 138.51 |
| MAs | MA(5) : | 176.93 |
MA(20) : | 175.49 |
| MA(100) : | 174.74 |
MA(250) : | 0 | |
| MACD | MACD : | -0.6 |
Signal : | -1.3 |
| %K %D | K(14,3) : | 57.4 |
D(3) : | 54.9 |
| RSI | RSI(14): 52 |
|||
| 52-week | High : | 212 | Low : | 86.98 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ IRTC ] has closed below upper band by 27.3%. Bollinger Bands are 26.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 178.23 - 179.11 | 179.11 - 180 |
| Low: | 173.82 - 174.74 | 174.74 - 175.68 |
| Close: | 175.13 - 176.58 | 176.58 - 178.04 |
Mon, 22 Dec 2025
Does iRhythm Technologies (IRTC) Asia-Pacific Data Shift Its Competitive Edge in Cardiac Monitoring? - simplywall.st
Mon, 22 Dec 2025
Why iRhythm (IRTC) Stock Is Up Today - Finviz
Mon, 22 Dec 2025
Morgan Stanley Raises iRhythm (IRTC) PT on MedTech Recovery Outlook - Yahoo Finance
Sun, 21 Dec 2025
(IRTC) Risk Channels and Responsive Allocation - Stock Traders Daily
Sat, 20 Dec 2025
Assenagon Asset Management S.A. Invests $13.39 Million in iRhythm Technologies $IRTC - MarketBeat
Thu, 18 Dec 2025
New Analyst Forecast: $IRTC Given $215 Price Target - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 32 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 111 (%) |
| Shares Short | 2,570 (K) |
| Shares Short P.Month | 2,330 (K) |
| EPS | -1.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.78 |
| Profit Margin | -7.4 % |
| Operating Margin | -2.1 % |
| Return on Assets (ttm) | -3.1 % |
| Return on Equity (ttm) | -53.2 % |
| Qtrly Rev. Growth | 30.7 % |
| Gross Profit (p.s.) | 15.34 |
| Sales Per Share | 21.8 |
| EBITDA (p.s.) | -1.28 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 74 (M) |
| Levered Free Cash Flow | 70 (M) |
| PE Ratio | -110.38 |
| PEG Ratio | 0 |
| Price to Book value | 46.59 |
| Price to Sales | 8.09 |
| Price to Cash Flow | 77.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|